Zobrazeno 1 - 9 of 9 pro vyhledávání: '"W. A. F. Marijt"'
1
Akademický článek
Microarray Gene Expression Analysis to Evaluate Cell Type Specific Expression of Targets Relevant for Immunotherapy of Hematological Malignancies.
Autor: M J Pont, M W Honders, A N Kremer, C van Kooten, C Out, P S Hiemstra, H C de Boer, M J Jager, E Schmelzer, R G Vries, A S Al Hinai, W G Kroes, R Monajemi, J J Goeman, S Böhringer, W A F Marijt, J H F Falkenburg, M Griffioen
Publikováno v: PLoS ONE, Vol 11, Iss 5, p e0155165 (2016)
Cellular immunotherapy has proven to be effective in the treatment of hematological cancers by donor lymphocyte infusion after allogeneic hematopoietic stem cell transplantation and more recently by targeted therapy with chimeric antigen or T-cell re
Externí odkaz: https://doaj.org/article/050040751d6c476f9999813834a75aa9
Zobrazit plný text záznamu
2
Reduced-intensity conditioning allogeneic stem cell transplantation with donor T-cell depletion using alemtuzumab added to the graft (‘Campath in the bag’)
Autor: J.H.F. Falkenburg, von dem Borne Pa, W. A. F. Marijt, Willem E. Fibbe, C. W. J. Starrenburg, R. Willemze, Halkes Sj
Publikováno v: Current Opinion in Oncology. 21:S23-S26
Allogeneicstemcelltransplantation(alloSCT)isapoten-tially curative treatment for patients with haematologicalmalignancies. Traditionally, myeloablative conditioningregimens have been used that induce considerabletoxicity, limiting the procedure to yo
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0322f2f9de4b18af4ebe44be4f595046
https://doi.org/10.1097/01.cco.0000357472.76337.0e
Zobrazit plný text záznamu
3
Minor histocompatibility antigens as targets of graft-versus-leukemia reactions
Autor: Jhf Falkenburg, W. A. F. Marijt, Roelof Willemze, Mirjam H.M. Heemskerk
Publikováno v: Current Opinion in Hematology. 9:497-502
The main advantage of allogeneic stem cell transplantation over autologous stem cell transplantation for hematologic malignancies is the ability to perform cellular immunotherapy using donor-derived immune effector cells after transplantation. In HLA
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::74a01bb5784e22660175d8136ed31556
https://doi.org/10.1097/00062752-200211000-00005
Zobrazit plný text záznamu
4
In Vivo T Cell Depletion Using Rabbit Derived ATG Leads to An Increased EBV-PTLD Risk Due to An Induced Imbalance Between B and T Cell Recovery Which Is Not Seen After Horse Derived ATG or Alemtuzumab
Autor: P. van Balen, M. van de Meent, Inge Jedema, J.H. Veelken, C. W. J. Starrenburg, P.A. von dem Borne, H.M. van Egmond, W. A. F. Marijt, J.H.F. Falkenburg, J. Olde Wolbers, Constantijn J.M. Halkes
Publikováno v: Blood, 118(21), 864-864
Abstract 1979 Control of replication of endogenous viruses like CMV and EBV is fully dependent on CMV or EBV specific T cells after allogeneic stem cell transplantation (alloSCT). In the absence of specific CD8 T cell control, proliferation of EBV in
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6bffd9f8dab133593d82856fa693d0a2
https://hdl.handle.net/1887/97984
Zobrazit plný text záznamu
5
Minor histocompatibility antigens HA-1-, -2-, and -4-, and HY-specific cytotoxic T-cell clones inhibit human hematopoietic progenitor cell growth by a mechanism that is dependent on direct cell-cell contact
Autor: J.H.F. Falkenburg, J.J. van Rood, W. A. F. Marijt, W. F. J. Veenhof, R. Willemze, E.A.J.M. Goulmy
Publikováno v: Blood
HLA-identical bone marrow transplantation (BMT) may be complicated by graft-versus-host disease or graft rejection. Both complications are thought to be initiated by recognition of minor histocompatibility (mH) antigens by HLA-restricted mH-antigen-s
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::055ccc5801072b6339280b2141096de6
https://doi.org/10.1182/blood.v82.12.3778.3778
Zobrazit plný text záznamu
6
Minor histocompatibility antigen-specific cytotoxic T cell lines, capable of lysing human hematopoietic progenitor cells, can be generated in vitro by stimulation with HLA-identical bone marrow cells
Autor: W. A. F. Marijt, J.H.F. Falkenburg, W. F. J. Veenhof, Anneke Brand, J.J. van Rood, R. Willemze, E.A.J.M. Goulmy, W. E. Fibbe
Publikováno v: The Journal of Experimental Medicine
J. Exp. Med.
J. Exp. Med., 173, 101-109
Recipient-antidonor alloreactivity before HLA genotypically identical bone marrow transplantation (BMT) between donor-recipient pairs that are negative in the mixed lymphocyte reaction (MLR), the cell-mediated lympholysis (CML) assay, and the lymphoc
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::629dfc2710159bdfa933a56d46be7621
http://europepmc.org/articles/PMC2118770
Zobrazit plný text záznamu
8
Akademický článek
Minor histocompatibility antigens as targets of graft-versus-leukemia reactions.
Autor: J. H. F. Falkenburg, W. A. F. Marijt, M. H. M. Heemskerk, R. Willemze
Publikováno v: Current Opinion in Hematology; Nov2002, Vol. 9 Issue 6, p497-502, 6p
Zobrazit plný text záznamu
9
Lymphokine-activated killer cells selectively kill tumor cells in bone marrow without compromising bone marrow stem cell function in vitro
Autor: S. A. P. Van Luxemburg-Heys, J.J. van Rood, P. J. Voogt, M. R. M. Van Den Brink, Anneke Brand, W. A. F. Marijt
Publikováno v: Blood. 74:354-360
Although it has been demonstrated that lymphokine-activated killer (LAK) cells kill tumor cells in a selective way without being toxic to a variety of normal cells, contradictory results exist about the possible toxicity of natural killer (NK) and LA
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::464a26a9f97a3254b2a639d23d29ea82
https://doi.org/10.1182/blood.v74.1.354.354
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje